ALVO
Price
$8.34
Change
+$0.22 (+2.71%)
Updated
Sep 26 closing price
Capitalization
2.6B
46 days until earnings call
CTOR
Price
$2.00
Change
+$0.18 (+9.89%)
Updated
Sep 26 closing price
Capitalization
167.03M
Interact to see
Advertisement

ALVO vs CTOR

Header iconALVO vs CTOR Comparison
Open Charts ALVO vs CTORBanner chart's image
Alvotech
Price$8.34
Change+$0.22 (+2.71%)
Volume$258.36K
Capitalization2.6B
Citius Oncology
Price$2.00
Change+$0.18 (+9.89%)
Volume$286.12K
Capitalization167.03M
ALVO vs CTOR Comparison Chart in %
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. CTOR commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a StrongBuy and CTOR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ALVO: $8.34 vs. CTOR: $2.00)
Brand notoriety: ALVO and CTOR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 63% vs. CTOR: 37%
Market capitalization -- ALVO: $2.6B vs. CTOR: $167.03M
ALVO [@Pharmaceuticals: Generic] is valued at $2.6B. CTOR’s [@Pharmaceuticals: Generic] market capitalization is $167.03M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whileCTOR’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • CTOR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALVO and CTOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while CTOR’s TA Score has 5 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 4 bearish.
  • CTOR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CTOR is a better buy in the short-term than ALVO.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +5.84% price change this week, while CTOR (@Pharmaceuticals: Generic) price change was +13.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($2.6B) has a higher market cap than CTOR($167M). CTOR YTD gains are higher at: 73.913 vs. ALVO (-36.961). ALVO has higher annual earnings (EBITDA): 207M vs. CTOR (-25.48M). ALVO has more cash in the bank: 151M vs. CTOR (112). CTOR has less debt than ALVO: CTOR (3.8M) vs ALVO (1.27B). ALVO has higher revenues than CTOR: ALVO (560M) vs CTOR (0).
ALVOCTORALVO / CTOR
Capitalization2.6B167M1,556%
EBITDA207M-25.48M-812%
Gain YTD-36.96173.913-50%
P/E Ratio36.26N/A-
Revenue560M0-
Total Cash151M112134,821,429%
Total Debt1.27B3.8M33,368%
TECHNICAL ANALYSIS
Technical Analysis
ALVOCTOR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
41%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
57%
MACD
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
39%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
39%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
35%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
31%
Aroon
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAMCX96.240.86
+0.90%
T. Rowe Price Mid-Cap Growth Adv
WGMVX4.590.04
+0.88%
Wasatch Micro Cap Value Institutional
RSGFX12.160.09
+0.75%
Victory RS Select Growth C
MREGX15.420.07
+0.46%
BlackRock Unconstrained Equity R
MXPBX12.75N/A
N/A
Empower International Index Instl

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and VTRS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and VTRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+2.71%
VTRS - ALVO
26%
Poorly correlated
+0.32%
EBS - ALVO
25%
Poorly correlated
+1.95%
CRON - ALVO
23%
Poorly correlated
-0.38%
PBH - ALVO
21%
Poorly correlated
+0.40%
PRGO - ALVO
21%
Poorly correlated
+3.32%
More

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and TKNO have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
+9.89%
TKNO - CTOR
14%
Poorly correlated
+4.84%
UTHR - CTOR
10%
Poorly correlated
+1.70%
ALVO - CTOR
4%
Poorly correlated
+2.71%
PRFX - CTOR
4%
Poorly correlated
N/A
SHPH - CTOR
4%
Poorly correlated
-3.26%
More